Janney Montgomery Scott’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$281K Hold
4,245
﹤0.01% 2786
2026
Q1
$230K Sell
4,245
-200
-4% -$11.1K ﹤0.01% 2561
2025
Q4
$249K Buy
4,445
+77
+2% +$3.99K ﹤0.01% 2674
2025
Q3
$209K Buy
+4,368
New +$195K ﹤0.01% 2714
2025
Q2
Sell
-4,723
Closed -$207K 2838
2025
Q1
$207K Sell
4,723
-70
-1% -$3.09K ﹤0.01% 2516
2024
Q4
$206K Hold
4,793
﹤0.01% 2539
2024
Q3
$213K Sell
4,793
-930
-16% -$39.8K ﹤0.01% 2482
2024
Q2
$228K Sell
5,723
-112
-2% -$4.54K ﹤0.01% 2376
2024
Q1
$252K Hold
5,835
﹤0.01% 2442
2023
Q4
$243K Hold
5,835
﹤0.01% 2360
2023
Q3
$232K Buy
5,835
+500
+9% +$21.2K ﹤0.01% 2299
2023
Q2
$219K Hold
5,335
﹤0.01% 2415
2023
Q1
$219K Hold
5,335
﹤0.01% 2240
2022
Q4
$218K Hold
5,335
﹤0.01% 2319
2022
Q3
$214K Sell
5,335
-55
-1% -$2.35K ﹤0.01% 2243
2022
Q2
$228K Sell
5,390
-642
-11% -$26.9K ﹤0.01% 2067
2022
Q1
$273K Sell
6,032
-856
-12% -$37.6K ﹤0.01% 1938
2021
Q4
$318K Buy
+6,888
New +$326K ﹤0.01% 1969
2018
Q4
Sell
-35,923
Closed -$1.74M 2071
2018
Q3
$1.74M Buy
+35,923
New +$1.7M 0.02% 750

Other funds holding XPH

Janney Montgomery Scott's XPH Position: Q2 2026 in Review

Janney Montgomery Scott held its State Street SPDR S&P Pharmaceuticals ETF (XPH) position steady in Q2 2026 at 4,245 shares worth $281K. The position accounts for ﹤0.01% of the portfolio, ranked #2786.

Janney Montgomery Scott first reported a position in XPH in Q3 2018 and has held it in 19 quarters since. The position peaked at $1.74M in Q3 2018. 93 funds tracked by Wall St. Rank hold XPH as of Q2 2026.

  • Janney Montgomery Scott held 4,245 shares of State Street SPDR S&P Pharmaceuticals ETF worth $281K as of Q2 2026.
  • Janney Montgomery Scott left its State Street SPDR S&P Pharmaceuticals ETF share count unchanged in Q2 2026.
  • State Street SPDR S&P Pharmaceuticals ETF made up ﹤0.01% of Janney Montgomery Scott's portfolio in Q2 2026, its #2786 holding.
  • Janney Montgomery Scott first reported a position in State Street SPDR S&P Pharmaceuticals ETF in Q3 2018 and has held it in 19 quarters since.
  • Janney Montgomery Scott's State Street SPDR S&P Pharmaceuticals ETF position peaked at $1.74M in Q3 2018.
  • 93 funds tracked by Wall St. Rank held State Street SPDR S&P Pharmaceuticals ETF as of Q2 2026.

Based on Janney Montgomery Scott's 13F filing for Q2 2026, filed 5 Aug 2026.